Biotechnology
The Biotechnology industry has a total of 610 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.25 billion.
Market Cap
1.12T
Revenue
105.25B
Profits
-42.74B
PE Ratio
n/a
Profit Margin
-40.61%
Dividend Yield
0.04%
610 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.65B | 0.55% | 1,151,979 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.50B | -0.34% | 871,639 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 58.81B | 3.56% | 901,623 | 3.21B |
| 4 | ARGX | argenx SE | 56.59B | -0.03% | 268,702 | 3.68B |
| 5 | INSM | Insmed Incorporated | 43.62B | -2.16% | 1,996,641 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 37.69B | 1.63% | 368,547 | 5.00B |
| 7 | BNTX | BioNTech SE | 24.69B | 3.00% | 1,046,067 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.00B | 0.76% | 2,521,695 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.74B | 0.09% | 1,402,736 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.63B | 1.66% | 1,227,897 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.00B | 1.65% | 1,498,029 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.51B | 0.05% | 4,846,158 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 13.82B | 1.54% | 1,743,713 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.74B | 1.02% | 1,398,632 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.65B | 1.52% | 250,115 | 740.64M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.40B | 2.19% | 2,954,550 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.83B | 1.63% | 681,882 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.90B | 2.50% | 2,086,428 | 2.29B |
| 19 | RNA | Avidity Biosciences, Inc. | 10.78B | 0.01% | 1,747,650 | 20.87M |
| 20 | JAZZ | Jazz Pharmaceuticals plc | 10.75B | -1.74% | 905,185 | 4.16B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | -1.37% | 3,575,709 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 10.07B | -1.85% | 1,472,057 | 1.22B |
| 23 | ABVX | ABIVAX Société Anonyme | 9.80B | -1.99% | 919,646 | 7.07M |
| 24 | MRNA | Moderna, Inc. | 9.77B | 1.05% | 6,494,963 | 2.23B |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.54B | -0.22% | 1,297,664 | 1.24B |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.39B | -0.60% | 761,217 | 741.17M |
| 27 | CYTK | Cytokinetics, Incorporated | 8.33B | 0.89% | 1,948,204 | 87.21M |
| 28 | NUVL | Nuvalent, Inc. | 7.94B | -0.65% | 704,615 | - |
| 29 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.84B | 23.34% | 7,066,452 | 829.45M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 7.61B | 0.41% | 538,706 | 561.26M |
| 31 | MRUS | Merus N.V. | 7.29B | 0.07% | 871,256 | 56.61M |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.17B | -1.22% | 599,823 | 174.33M |
| 33 | CAI | Caris Life Sciences, Inc. | 7.08B | -1.92% | 1,853,939 | 649.06M |
| 34 | PTCT | PTC Therapeutics, Inc. | 6.92B | 4.00% | 15,474,499 | 1.78B |
| 35 | CDTX | Cidara Therapeutics, Inc. | 6.91B | 0.05% | 693,166 | 302.00K |
| 36 | PCVX | Vaxcyte, Inc. | 6.50B | -1.17% | 845,242 | - |
| 37 | KRYS | Krystal Biotech, Inc. | 6.35B | 0.91% | 304,951 | 373.16M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.14B | 1.69% | 3,157,448 | - |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.63B | 0.23% | 1,124,270 | 209.22M |
| 40 | CRSP | CRISPR Therapeutics AG | 5.08B | -0.50% | 2,083,916 | 38.34M |
| 41 | LEGN | Legend Biotech Corporation | 5.08B | -2.45% | 1,267,703 | 909.05M |
| 42 | TGTX | TG Therapeutics, Inc. | 4.88B | 1.30% | 1,607,667 | 531.90M |
| 43 | KYMR | Kymera Therapeutics, Inc. | 4.88B | 2.76% | 835,815 | 43.74M |
| 44 | APGE | Apogee Therapeutics, Inc. | 4.75B | -0.75% | 458,771 | - |
| 45 | PRAX | Praxis Precision Medicines, Inc. | 4.71B | 2.33% | 677,871 | 7.46M |
| 46 | NAMS | NewAmsterdam Pharma Company N.V. | 4.70B | 2.50% | 827,647 | 35.24M |
| 47 | CELC | Celcuity Inc. | 4.64B | 1.28% | 852,046 | - |
| 48 | ADMA | ADMA Biologics, Inc. | 4.56B | -0.36% | 4,072,183 | 488.56M |
| 49 | BLTE | Belite Bio, Inc | 4.49B | 0.72% | 118,338 | - |
| 50 | AKRO | Akero Therapeutics, Inc. | 4.47B | -0.02% | 1,040,631 | - |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.40B | 4.05% | 1,096,255 | - |
| 52 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.37B | 2.95% | 990,514 | 1.54M |
| 53 | ACLX | Arcellx, Inc. | 4.24B | 0.34% | 1,150,452 | 35.90M |
| 54 | CNTA | Centessa Pharmaceuticals plc | 4.23B | 0.10% | 2,206,712 | 15.00M |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.20B | 1.72% | 1,880,005 | 1.05B |
| 56 | IMVT | Immunovant, Inc. | 4.15B | -1.04% | 908,490 | - |
| 57 | VKTX | Viking Therapeutics, Inc. | 4.10B | 2.28% | 2,460,704 | - |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 3.79B | 0.75% | 1,924,893 | 317.93M |
| 59 | MIRM | Mirum Pharmaceuticals, Inc. | 3.76B | 1.91% | 402,619 | 471.79M |
| 60 | CGON | CG Oncology, Inc. | 3.62B | -1.47% | 930,785 | 2.17M |
| 61 | IRON | Disc Medicine, Inc. | 3.54B | 1.32% | 606,561 | - |
| 62 | XENE | Xenon Pharmaceuticals Inc. | 3.44B | 1.25% | 1,070,945 | 7.50M |
| 63 | MLYS | Mineralys Therapeutics, Inc. | 3.43B | 2.75% | 1,212,246 | - |
| 64 | TARS | Tarsus Pharmaceuticals, Inc. | 3.42B | 2.05% | 323,711 | 366.10M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.31B | 1.14% | 61,162 | 664.23M |
| 66 | RARE | Ultragenyx Pharmaceutical Inc. | 3.25B | 0.70% | 1,304,200 | 630.60M |
| 67 | TVTX | Travere Therapeutics, Inc. | 3.24B | 0.69% | 1,112,522 | 435.83M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.16B | 5.27% | 1,975,495 | 240.00M |
| 69 | IDYA | IDEAYA Biosciences, Inc. | 3.15B | 1.10% | 1,107,062 | 214.83M |
| 70 | FOLD | Amicus Therapeutics, Inc. | 3.09B | 1.52% | 3,080,904 | 598.70M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 3.03B | 0.99% | 1,707,055 | 70.79M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.02B | 1.78% | 3,051,698 | - |
| 73 | ADPT | Adaptive Biotechnologies Corporation | 3.01B | -2.95% | 1,877,882 | 252.75M |
| 74 | AAPG | Ascentage Pharma Group International | 3.00B | -0.77% | 9,481 | 54.52M |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.88B | -0.68% | 1,478,022 | 578.20M |
| 76 | DNLI | Denali Therapeutics Inc. | 2.85B | 1.41% | 978,617 | - |
| 77 | LQDA | Liquidia Corporation | 2.76B | -1.67% | 1,863,813 | 69.22M |
| 78 | NUVB | Nuvation Bio Inc. | 2.75B | 1.65% | 6,995,151 | 26.75M |
| 79 | APLS | Apellis Pharmaceuticals, Inc. | 2.73B | 2.81% | 1,826,825 | 1.02B |
| 80 | EWTX | Edgewise Therapeutics, Inc. | 2.70B | 6.07% | 1,306,974 | - |
| 81 | SLNO | Soleno Therapeutics, Inc. | 2.66B | -0.44% | 1,911,289 | 98.68M |
| 82 | TERN | Terns Pharmaceuticals, Inc. | 2.59B | -2.03% | 1,952,179 | - |
| 83 | OCUL | Ocular Therapeutix, Inc. | 2.59B | 0.08% | 2,366,922 | 55.78M |
| 84 | BEAM | Beam Therapeutics Inc. | 2.47B | 1.38% | 1,367,424 | 55.70M |
| 85 | SYRE | Spyre Therapeutics, Inc. | 2.31B | 1.88% | 503,212 | - |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.30B | 0.92% | 17,245,193 | 43.69M |
| 87 | MESO | Mesoblast Limited | 2.27B | 8.16% | 451,941 | 17.20M |
| 88 | OLMA | Olema Pharmaceuticals, Inc. | 2.21B | 7.86% | 4,122,229 | - |
| 89 | ZLAB | Zai Lab Limited | 2.21B | 0.35% | 2,422,957 | 441.63M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | 8.27% | 3,246,881 | 2.41B |
| 91 | ZBIO | Zenas BioPharma, Inc. | 2.18B | 1.68% | 230,351 | 15.00M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.16B | 0.55% | 1,410,581 | 265.81M |
| 93 | VERA | Vera Therapeutics, Inc. | 2.13B | 13.25% | 3,201,785 | - |
| 94 | IBRX | ImmunityBio, Inc. | 2.10B | 2.40% | 8,487,399 | 82.56M |
| 95 | JANX | Janux Therapeutics, Inc. | 2.09B | -0.14% | 1,557,588 | 10.00M |
| 96 | GPCR | Structure Therapeutics Inc. | 2.08B | 0.15% | 957,373 | - |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | 0.62% | 638,945 | 825.94M |
| 98 | ZYME | Zymeworks Inc. | 2.05B | 4.39% | 2,198,085 | 134.48M |
| 99 | VCEL | Vericel Corporation | 2.04B | -5.10% | 664,458 | 258.72M |
| 100 | GLPG | Galapagos NV | 2.04B | 0.03% | 57,029 | 336.64M |
| 101 | IMCR | Immunocore Holdings plc | 2.03B | 0.65% | 454,490 | 379.59M |
| 102 | SION | Sionna Therapeutics, Inc. | 1.95B | -1.11% | 94,455 | - |
| 103 | DNTH | Dianthus Therapeutics, Inc. | 1.88B | -0.34% | 695,871 | 3.08M |
| 104 | MAZE | Maze Therapeutics, Inc. | 1.83B | 3.49% | 343,493 | 2.50M |
| 105 | PHVS | Pharvaris N.V. | 1.80B | 8.92% | 615,636 | - |
| 106 | STOK | Stoke Therapeutics, Inc. | 1.78B | 4.66% | 691,981 | 205.63M |
| 107 | CLDX | Celldex Therapeutics, Inc. | 1.78B | 1.32% | 462,131 | 2.60M |
| 108 | NRIX | Nurix Therapeutics, Inc. | 1.74B | 1.18% | 1,169,577 | 83.69M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.73B | 2.16% | 1,959,319 | 111.30M |
| 110 | QURE | uniQure N.V. | 1.72B | -1.18% | 983,852 | 15.75M |
| 111 | IMNM | Immunome, Inc. | 1.71B | 1.80% | 1,010,084 | 9.68M |
| 112 | TRVI | Trevi Therapeutics, Inc. | 1.70B | 16.99% | 5,476,399 | - |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 2.16% | 1,857,169 | 44.79M |
| 114 | MNKD | MannKind Corporation | 1.65B | 0.37% | 2,055,739 | 313.79M |
| 115 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.65B | 0.81% | 955,512 | -665.00K |
| 116 | INVA | Innoviva, Inc. | 1.62B | -0.05% | 1,063,240 | 388.52M |
| 117 | MBX | MBX Biosciences, Inc. | 1.52B | 7.03% | 545,938 | - |
| 118 | UPB | Upstream Bio, Inc. | 1.51B | -2.88% | 509,981 | 2.80M |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.47B | -0.20% | 306,967 | - |
| 120 | TNGX | Tango Therapeutics, Inc. | 1.45B | 1.80% | 2,061,308 | 66.50M |
| 121 | ARDX | Ardelyx, Inc. | 1.44B | 3.67% | 2,813,602 | 398.23M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.40B | 2.97% | 370,764 | - |
| 123 | RLAY | Relay Therapeutics, Inc. | 1.39B | -0.25% | 1,192,648 | 8.36M |
| 124 | URGN | UroGen Pharma Ltd. | 1.38B | 6.25% | 1,121,424 | 96.52M |
| 125 | NKTR | Nektar Therapeutics | 1.34B | 8.85% | 863,171 | 62.60M |
| 126 | TSHA | Taysha Gene Therapies, Inc. | 1.33B | 5.88% | 2,753,375 | 6.31M |
| 127 | SEPN | Septerna, Inc. | 1.32B | 5.72% | 681,035 | 22.05M |
| 128 | PGEN | Precigen, Inc. | 1.32B | 1.91% | 3,300,392 | 6.31M |
| 129 | SVRA | Savara Inc. | 1.29B | 4.08% | 2,340,437 | - |
| 130 | IMTX | Immatics N.V. | 1.29B | -3.28% | 641,521 | 99.45M |
| 131 | ELVN | Enliven Therapeutics, Inc. | 1.29B | -0.09% | 607,200 | - |
| 132 | WVE | Wave Life Sciences Ltd. | 1.28B | 3.23% | 1,802,834 | 109.23M |
| 133 | BHVN | Biohaven Ltd. | 1.26B | 0.74% | 2,765,507 | - |
| 134 | XNCR | Xencor, Inc. | 1.24B | 0.70% | 1,231,067 | 150.13M |
| 135 | CVAC | CureVac N.V. | 1.23B | 3.79% | 5,044,431 | 83.00M |
| 136 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.22B | 0.34% | 850,311 | 42.34M |
| 137 | INBX | Inhibrx Biosciences, Inc. | 1.22B | 1.19% | 145,994 | 1.40M |
| 138 | PHAR | Pharming Group N.V. | 1.20B | 4.06% | 10,574 | 362.27M |
| 139 | MNMD | Mind Medicine (MindMed) Inc. | 1.19B | 1.85% | 1,147,135 | - |
| 140 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | 1.13% | 1,678,566 | 266.14M |
| 141 | KOD | Kodiak Sciences Inc. | 1.19B | -2.39% | 569,711 | - |
| 142 | PVLA | Palvella Therapeutics, Inc. | 1.18B | 5.40% | 245,899 | - |
| 143 | TYRA | Tyra Biosciences, Inc. | 1.18B | 0.59% | 555,119 | - |
| 144 | ANAB | AnaptysBio, Inc. | 1.17B | 1.59% | 575,045 | 169.47M |
| 145 | FTRE | Fortrea Holdings Inc. | 1.17B | -1.17% | 1,501,671 | 2.76B |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | 1.72% | 1,926,410 | - |
| 147 | NVAX | Novavax, Inc. | 1.13B | 3.89% | 2,716,818 | 1.06B |
| 148 | OCS | Oculis Holding AG | 1.09B | -2.17% | 62,645 | 992.00K |
| 149 | ABCL | AbCellera Biologics Inc. | 1.09B | 0.55% | 9,281,490 | 35.33M |
| 150 | SANA | Sana Biotechnology, Inc. | 1.07B | 14.53% | 9,684,014 | - |
| 151 | PHAT | Phathom Pharmaceuticals, Inc. | 1.06B | 1.61% | 446,076 | 147.19M |
| 152 | KURA | Kura Oncology, Inc. | 1.04B | 3.36% | 1,983,467 | 104.03M |
| 153 | GLUE | Monte Rosa Therapeutics, Inc. | 1.04B | -0.19% | 637,630 | 181.54M |
| 154 | BCAX | Bicara Therapeutics Inc. | 1.04B | 2.93% | 330,546 | - |
| 155 | MDXG | MiMedx Group, Inc. | 1.02B | -1.01% | 506,154 | 393.44M |
| 156 | TBPH | Theravance Biopharma, Inc. | 1.01B | 5.39% | 845,288 | 80.33M |
| 157 | NTLA | Intellia Therapeutics, Inc. | 986.87M | -0.35% | 3,135,634 | 57.53M |
| 158 | MLTX | MoonLake Immunotherapeutics | 984.96M | 1.40% | 2,423,316 | - |
| 159 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 974.26M | -1.46% | 98,871 | - |
| 160 | IOVA | Iovance Biotherapeutics, Inc. | 968.60M | -1.61% | 6,728,992 | 250.43M |
| 161 | DAWN | Day One Biopharmaceuticals, Inc. | 966.18M | -0.21% | 1,313,349 | 133.67M |
| 162 | LENZ | LENZ Therapeutics, Inc. | 961.23M | 2.81% | 766,586 | 17.50M |
| 163 | CMPX | Compass Therapeutics, Inc. | 958.68M | 7.58% | 3,180,800 | 850.00K |
| 164 | NBTX | Nanobiotix S.A. | 953.80M | -4.00% | 158,646 | 11.93M |
| 165 | AVBP | ArriVent BioPharma, Inc. | 951.54M | 1.19% | 590,911 | - |
| 166 | SPRY | ARS Pharmaceuticals, Inc. | 945.98M | 3.13% | 2,743,482 | 142.77M |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 930.77M | -3.19% | 773,062 | 192.44M |
| 168 | RIGL | Rigel Pharmaceuticals, Inc. | 924.99M | 2.82% | 470,256 | 282.08M |
| 169 | RAPT | RAPT Therapeutics, Inc. | 921.66M | 10.98% | 828,684 | - |
| 170 | GHRS | GH Research PLC | 914.93M | -1.01% | 118,555 | - |
| 171 | VIR | Vir Biotechnology, Inc. | 889.01M | -0.78% | 1,891,988 | 16.86M |
| 172 | ERAS | Erasca, Inc. | 888.02M | 1.95% | 1,718,326 | - |
| 173 | RZLT | Rezolute, Inc. | 886.48M | 0.31% | 1,223,586 | - |
| 174 | ABUS | Arbutus Biopharma Corporation | 848.15M | 2.08% | 889,853 | 14.61M |
| 175 | VSTM | Verastem, Inc. | 820.44M | 3.71% | 2,715,728 | 13.38M |
| 176 | VALN | Valneva SE | 811.66M | 9.15% | 98,123 | 211.09M |
| 177 | ATAI | Atai Beckley N.V. | 803.77M | -0.27% | 2,334,477 | 3.02M |
| 178 | ARVN | Arvinas, Inc. | 797.67M | 2.48% | 1,689,228 | 312.30M |
| 179 | ALMS | Alumis Inc. | 797.57M | 4.23% | 1,155,735 | 22.12M |
| 180 | REPL | Replimune Group, Inc. | 789.14M | 5.56% | 1,172,579 | - |
| 181 | GOSS | Gossamer Bio, Inc. | 773.06M | 2.14% | 1,716,661 | 44.05M |
| 182 | CRMD | CorMedix Inc. | 760.31M | 2.66% | 2,183,485 | 214.30M |
| 183 | GERN | Geron Corporation | 759.64M | 2.59% | 6,223,569 | 183.40M |
| 184 | YDES | YD Bio Limited | 739.76M | 13.24% | 157,869 | 510.36K |
| 185 | ATXS | Astria Therapeutics, Inc. | 719.27M | 2.11% | 1,218,419 | 706.00K |
| 186 | CTMX | CytomX Therapeutics, Inc. | 715.02M | 1.69% | 1,746,166 | 113.63M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 713.49M | 1.68% | 60,112 | 107.27M |
| 188 | VTYX | Ventyx Biosciences, Inc. | 712.87M | -4.49% | 897,949 | - |
| 189 | KALV | KalVista Pharmaceuticals, Inc. | 712.70M | 6.17% | 1,928,881 | 1.43M |
| 190 | LXEO | Lexeo Therapeutics, Inc. | 702.87M | -0.93% | 516,871 | - |
| 191 | CGEM | Cullinan Therapeutics, Inc. | 693.56M | -0.42% | 1,316,850 | - |
| 192 | OMER | Omeros Corporation | 682.77M | 1.90% | 1,027,986 | - |
| 193 | CRVS | Corvus Pharmaceuticals, Inc. | 677.36M | 2.25% | 995,458 | - |
| 194 | RGNX | REGENXBIO Inc. | 671.26M | -1.41% | 906,264 | 161.32M |
| 195 | MGTX | MeiraGTx Holdings plc | 660.03M | 8.18% | 2,310,389 | 27.42M |
| 196 | PRME | Prime Medicine, Inc. | 656.81M | -0.27% | 1,990,374 | 5.98M |
| 197 | PROK | ProKidney Corp. | 637.77M | 0.95% | 1,581,122 | 744.00K |
| 198 | FDMT | 4D Molecular Therapeutics, Inc. | 627.91M | 2.90% | 650,331 | 120.00K |
| 199 | ANNX | Annexon, Inc. | 625.23M | -2.70% | 3,043,530 | - |
| 200 | FULC | Fulcrum Therapeutics, Inc. | 612.62M | -1.91% | 445,761 | 80.00M |
| 201 | IVA | Inventiva S.A. | 598.62M | 4.07% | 128,575 | 19.93M |
| 202 | ASMB | Assembly Biosciences, Inc. | 585.71M | -1.04% | 60,622 | 37.19M |
| 203 | EVMN | Evommune, Inc. | 583.81M | 3.52% | 41,242 | 3.00M |
| 204 | MNPR | Monopar Therapeutics Inc. | 583.79M | -1.25% | 83,359 | - |
| 205 | JBIO | Jade Biosciences, Inc. | 574.13M | -0.48% | 135,989 | - |
| 206 | MPLT | MapLight Therapeutics, Inc. | 566.90M | 1.41% | 361,953 | - |
| 207 | PRTA | Prothena Corporation plc | 561.72M | -0.62% | 449,678 | 11.79M |
| 208 | NAGE | Niagen Bioscience, Inc. | 551.81M | -2.13% | 599,114 | 124.71M |
| 209 | IVVD | Invivyd, Inc. | 543.18M | 2.64% | 2,154,557 | 50.04M |
| 210 | ALT | Altimmune, Inc. | 539.45M | 0.58% | 2,559,129 | 20.00K |
| 211 | ADCT | ADC Therapeutics SA | 536.39M | -1.37% | 388,151 | 75.21M |
| 212 | DSGN | Design Therapeutics, Inc. | 533.75M | -0.43% | 416,446 | - |
| 213 | KROS | Keros Therapeutics, Inc. | 533.16M | 1.04% | 1,600,337 | 246.72M |
| 214 | ENGN | enGene Holdings Inc. | 532.77M | 7.00% | 284,406 | - |
| 215 | LXRX | Lexicon Pharmaceuticals, Inc. | 519.66M | 1.42% | 771,897 | 70.86M |
| 216 | LYEL | Lyell Immunopharma, Inc. | 517.94M | 8.34% | 66,684 | 41.00K |
| 217 | DNA | Ginkgo Bioworks Holdings, Inc. | 517.78M | 4.59% | 930,347 | 180.61M |
| 218 | DRUG | Bright Minds Biosciences Inc. | 508.51M | 0.96% | 56,412 | - |
| 219 | BCYC | Bicycle Therapeutics plc | 507.08M | 6.40% | 314,955 | 28.34M |
| 220 | IMRX | Immuneering Corporation | 484.92M | 0.94% | 496,630 | - |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 484.16M | 2.38% | 1,075,105 | 84.39M |
| 222 | DBVT | DBV Technologies S.A. | 483.34M | -0.42% | 235,787 | 5.50M |
| 223 | DMAC | DiaMedica Therapeutics Inc. | 474.95M | 1.00% | 822,307 | - |
| 224 | ABSI | Absci Corporation | 464.65M | 0.65% | 2,836,536 | 2.82M |
| 225 | NBP | NovaBridge Biosciences | 444.93M | -1.03% | 298,340 | - |
| 226 | BNTC | Benitec Biopharma Inc. | 440.72M | 0.66% | 223,320 | - |
| 227 | ANRO | Alto Neuroscience, Inc. | 419.71M | 1.12% | 181,639 | - |
| 228 | PEPG | PepGen Inc. | 418.68M | 0.66% | 812,013 | - |
| 229 | LBRX | LB Pharmaceuticals Inc | 418.19M | 2.04% | 187,037 | - |
| 230 | SLDB | Solid Biosciences Inc. | 417.60M | 4.08% | 607,851 | - |
| 231 | LCTX | Lineage Cell Therapeutics, Inc. | 414.38M | -1.72% | 881,600 | 10.82M |
| 232 | AURA | Aura Biosciences, Inc. | 405.15M | 4.42% | 315,046 | - |
| 233 | ENTA | Enanta Pharmaceuticals, Inc. | 401.97M | 1.95% | 209,292 | 65.32M |
| 234 | TECX | Tectonic Therapeutic, Inc. | 400.34M | 0.66% | 258,299 | - |
| 235 | XOMA | XOMA Royalty Corporation | 399.85M | 1.46% | 45,759 | 47.11M |
| 236 | PRTC | PureTech Health plc | 398.48M | 0.06% | 1,648 | 6.39M |
| 237 | TENX | Tenax Therapeutics, Inc. | 384.20M | 0.74% | 217,241 | - |
| 238 | NMRA | Neumora Therapeutics, Inc. | 382.63M | 1.78% | 731,982 | - |
| 239 | GALT | Galectin Therapeutics Inc. | 371.36M | 0.88% | 187,460 | - |
| 240 | CLLS | Cellectis S.A. | 368.59M | -3.82% | 122,179 | 82.55M |
| 241 | OCGN | Ocugen, Inc. | 368.54M | 0.85% | 3,103,388 | 5.37M |
| 242 | AUTL | Autolus Therapeutics plc | 364.62M | -1.44% | 2,597,864 | 51.13M |
| 243 | TRDA | Entrada Therapeutics, Inc. | 361.48M | -0.40% | 153,968 | 61.52M |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 356.05M | 6.13% | 1,570,416 | - |
| 245 | AVXL | Anavex Life Sciences Corp. | 344.88M | 11.56% | 3,757,130 | - |
| 246 | FBRX | Forte Biosciences, Inc. | 340.22M | -4.55% | 128,136 | - |
| 247 | AVTX | Avalo Therapeutics, Inc. | 336.39M | -2.32% | 117,997 | 192.00K |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 336.35M | 3.92% | 283,680 | - |
| 249 | ALDX | Aldeyra Therapeutics, Inc. | 336.31M | 6.27% | 1,326,523 | - |
| 250 | VTVT | vTv Therapeutics Inc. | 335.04M | -3.16% | 3,596 | 17.00K |
| 251 | PALI | Palisade Bio, Inc. | 332.28M | 3.72% | 4,203,672 | - |
| 252 | PYXS | Pyxis Oncology, Inc. | 328.76M | -1.12% | 747,800 | 2.82M |
| 253 | NGNE | Neurogene Inc. | 325.13M | 1.21% | 153,081 | 925.00K |
| 254 | SLN | Silence Therapeutics plc | 323.08M | 7.72% | 236,910 | 25.83M |
| 255 | ALLO | Allogene Therapeutics, Inc. | 319.12M | 4.41% | 2,765,573 | 22.00K |
| 256 | DRTS | Alpha Tau Medical Ltd. | 318.89M | -4.10% | 68,736 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 318.27M | -4.21% | 689,171 | 33.98M |
| 258 | EPRX | Eupraxia Pharmaceuticals Inc. | 314.29M | 1.63% | 17,032 | - |
| 259 | CTNM | Contineum Therapeutics, Inc. | 314.00M | 0.47% | 117,450 | - |
| 260 | VNDA | Vanda Pharmaceuticals Inc. | 313.21M | 6.00% | 710,858 | 212.07M |
| 261 | ACRS | Aclaris Therapeutics, Inc. | 312.03M | 5.49% | 1,275,947 | 15.74M |
| 262 | RLMD | Relmada Therapeutics, Inc. | 307.27M | -1.64% | 761,431 | - |
| 263 | LRMR | Larimar Therapeutics, Inc. | 302.13M | -3.81% | 3,068,295 | - |
| 264 | CYBN | Cybin Inc. | 300.92M | -2.27% | 541,064 | - |
| 265 | OBIO | Orchestra BioMed Holdings, Inc. | 295.88M | -2.06% | 361,614 | 2.82M |
| 266 | CBIO | Crescent Biopharma, Inc. | 294.81M | 7.71% | 34,523 | - |
| 267 | MREO | Mereo BioPharma Group plc | 292.80M | 2.79% | 1,236,450 | 500.00K |
| 268 | ACIU | AC Immune SA | 289.90M | 1.03% | 159,752 | 5.48M |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 286.71M | 3.65% | 286,977 | - |
| 270 | TARA | Protara Therapeutics, Inc. | 285.74M | -2.05% | 444,786 | - |
| 271 | ABEO | Abeona Therapeutics Inc. | 279.09M | 5.53% | 2,552,393 | 400.00K |
| 272 | FHTX | Foghorn Therapeutics Inc. | 272.01M | 1.91% | 110,540 | 24.52M |
| 273 | FENC | Fennec Pharmaceuticals Inc. | 268.65M | -1.06% | 247,411 | 38.79M |
| 274 | OABI | OmniAb, Inc. | 267.76M | - | 353,965 | 21.09M |
| 275 | MIST | Milestone Pharmaceuticals Inc. | 265.13M | 5.67% | 3,452,007 | - |
| 276 | ARMP | Armata Pharmaceuticals, Inc. | 262.30M | 1.69% | 40,751 | 5.05M |
| 277 | CCCC | C4 Therapeutics, Inc. | 259.73M | 8.06% | 1,773,485 | 30.11M |
| 278 | IMMP | Immutep Limited | 258.92M | 4.42% | 145,930 | 3.31M |
| 279 | ACHV | Achieve Life Sciences, Inc. | 257.65M | 5.45% | 1,126,341 | - |
| 280 | PBYI | Puma Biotechnology, Inc. | 254.48M | 2.02% | 354,360 | 212.00M |
| 281 | CADL | Candel Therapeutics, Inc. | 253.63M | 3.36% | 969,324 | - |
| 282 | HUMA | Humacyte, Inc. | 249.07M | 0.76% | 3,307,187 | 1.57M |
| 283 | ZURA | Zura Bio Limited | 247.09M | 1.33% | 359,104 | - |
| 284 | PRQR | ProQR Therapeutics N.V. | 246.51M | 8.84% | 687,269 | 18.86M |
| 285 | AVIR | Atea Pharmaceuticals, Inc. | 238.29M | 0.66% | 199,393 | - |
| 286 | CAPR | Capricor Therapeutics, Inc. | 237.28M | 12.83% | 2,486,911 | 11.13M |
| 287 | EDIT | Editas Medicine, Inc. | 234.28M | 0.42% | 1,057,733 | 46.38M |
| 288 | SGMT | Sagimet Biosciences Inc. | 230.25M | 1.43% | 306,179 | - |
| 289 | MDWD | MediWound Ltd. | 230.14M | -1.37% | 79,565 | 20.93M |
| 290 | CABA | Cabaletta Bio, Inc. | 228.15M | 7.73% | 3,150,394 | - |
| 291 | ETHZ | ETHZilla Corporation | 227.26M | 4.73% | 572,636 | 4.11M |
| 292 | TNYA | Tenaya Therapeutics, Inc. | 226.45M | 10.57% | 2,228,675 | - |
| 293 | VYGR | Voyager Therapeutics, Inc. | 224.07M | 1.51% | 434,165 | 31.32M |
| 294 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 220.12M | 4.49% | 129,325 | - |
| 295 | BDTX | Black Diamond Therapeutics, Inc. | 215.37M | -2.33% | 845,113 | 70.00M |
| 296 | TLSA | Tiziana Life Sciences Ltd | 212.69M | -1.65% | 212,847 | - |
| 297 | AARD | Aardvark Therapeutics, Inc. | 210.55M | 3.20% | 167,095 | - |
| 298 | GNLX | Genelux Corporation | 210.29M | 5.67% | 160,676 | 8.00K |
| 299 | SLS | SELLAS Life Sciences Group, Inc. | 207.97M | 1.39% | 3,728,830 | - |
| 300 | HRTX | Heron Therapeutics, Inc. | 205.37M | 2.75% | 1,899,294 | 155.10M |
| 301 | GUTS | Fractyl Health, Inc. | 202.83M | 1.37% | 1,779,127 | 3.00K |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 197.63M | 3.83% | 143,905 | 1.09M |
| 303 | RANI | Rani Therapeutics Holdings, Inc. | 196.85M | 0.62% | 1,724,786 | 1.20M |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 193.21M | - | 715,478 | 97.60M |
| 305 | SABS | SAB Biotherapeutics, Inc. | 192.33M | 2.80% | 238,275 | 114.70K |
| 306 | QNCX | Quince Therapeutics, Inc. | 192.10M | 29.21% | 2,992,825 | - |
| 307 | VTGN | Vistagen Therapeutics, Inc. | 179.31M | -3.20% | 454,776 | 721.00K |
| 308 | IPHA | Innate Pharma S.A. | 177.84M | 1.61% | 31,783 | 14.84M |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 177.59M | 7.10% | 1,226,200 | 10.30M |
| 310 | CRBU | Caribou Biosciences, Inc. | 175.72M | 0.53% | 797,243 | 9.30M |
| 311 | CAMP | Camp4 Therapeutics Corporation | 169.71M | 7.10% | 50,744 | 3.80M |
| 312 | NTHI | NeOnc Technologies Holdings, Inc. | 169.43M | -1.58% | 91,916 | 59.99K |
| 313 | SAVA | Cassava Sciences, Inc. | 163.76M | 11.51% | 2,177,994 | - |
| 314 | VOR | Vor Biopharma Inc. | 162.26M | -0.13% | 332,947 | - |
| 315 | ACTU | Actuate Therapeutics, Inc. | 160.38M | 10.40% | 122,841 | - |
| 316 | ELTX | Elicio Therapeutics, Inc. | 159.90M | 2.23% | 64,852 | - |
| 317 | CHRS | Coherus Oncology, Inc. | 158.34M | 2.34% | 972,669 | 277.73M |
| 318 | CNTB | Connect Biopharma Holdings Limited | 158.21M | 2.16% | 584,575 | 762.00K |
| 319 | CRDF | Cardiff Oncology, Inc. | 157.62M | 10.90% | 1,008,130 | 501.00K |
| 320 | CDXS | Codexis, Inc. | 157.16M | 3.87% | 913,714 | 52.93M |
| 321 | SGMO | Sangamo Therapeutics, Inc. | 156.17M | 11.80% | 6,938,489 | 32.88M |
| 322 | NVCT | Nuvectis Pharma, Inc. | 155.23M | -0.49% | 108,125 | - |
| 323 | AGEN | Agenus Inc. | 154.74M | 3.88% | 548,752 | 106.83M |
| 324 | ANIX | Anixa Biosciences, Inc. | 152.73M | 7.41% | 209,868 | - |
| 325 | MCRB | Seres Therapeutics, Inc. | 152.61M | -0.30% | 140,321 | 351.00K |
| 326 | MOLN | Molecular Partners AG | 149.42M | 2.50% | 717 | 856.30K |
| 327 | CGEN | Compugen Ltd. | 148.72M | - | 204,878 | 6.90M |
| 328 | ALEC | Alector, Inc. | 147.35M | 5.47% | 1,337,771 | 69.05M |
| 329 | PLX | Protalix BioTherapeutics, Inc. | 147.17M | 2.23% | 614,573 | 61.84M |
| 330 | CGTX | Cognition Therapeutics, Inc. | 145.65M | 13.01% | 1,061,399 | - |
| 331 | IMMX | Immix Biopharma, Inc. | 144.38M | - | 238,681 | - |
| 332 | SRZN | Surrozen, Inc. | 140.96M | 2.72% | 57,899 | 3.60M |
| 333 | IRD | Opus Genetics, Inc. | 139.31M | 2.02% | 256,974 | 14.63M |
| 334 | MRSN | Mersana Therapeutics, Inc. | 137.67M | 0.49% | 46,578 | 33.18M |
| 335 | PRLD | Prelude Therapeutics Incorporated | 137.60M | 5.03% | 296,549 | 10.50M |
| 336 | UNCY | Unicycive Therapeutics, Inc. | 135.40M | 10.14% | 511,479 | - |
| 337 | STTK | Shattuck Labs, Inc. | 134.79M | 5.97% | 136,892 | 1.00M |
| 338 | INO | Inovio Pharmaceuticals, Inc. | 134.66M | 8.29% | 1,330,624 | 182.34K |
| 339 | EXOZ | eXoZymes, Inc. | 133.78M | -0.31% | 2,481 | -700.00 |
| 340 | COYA | Coya Therapeutics, Inc. | 133.50M | 5.28% | 147,276 | 3.99M |
| 341 | ACOG | Alpha Cognition Inc. | 132.19M | -0.25% | 41,193 | 7.43M |
| 342 | SPRO | Spero Therapeutics, Inc. | 131.27M | -0.43% | 363,095 | 40.55M |
| 343 | ANVS | Annovis Bio, Inc. | 130.39M | 2.07% | 2,925,405 | - |
| 344 | NKTX | Nkarta, Inc. | 129.98M | 1.10% | 652,661 | - |
| 345 | NBY | NovaBay Pharmaceuticals, Inc. | 128.53M | 8.50% | 136,079 | 10.30M |
| 346 | FATE | Fate Therapeutics, Inc. | 126.89M | 3.77% | 753,579 | 7.14M |
| 347 | CLYM | Climb Bio, Inc. | 126.05M | 2.70% | 397,652 | - |
| 348 | DTIL | Precision BioSciences, Inc. | 122.53M | 4.30% | 112,212 | 698.00K |
| 349 | KLRS | Kalaris Therapeutics, Inc. | 120.44M | 2.88% | 29,867 | - |
| 350 | CNTX | Context Therapeutics Inc. | 120.44M | 0.89% | 932,145 | - |
| 351 | ABOS | Acumen Pharmaceuticals, Inc. | 118.12M | 0.52% | 158,007 | - |
| 352 | SPRB | Spruce Biosciences, Inc. | 117.74M | 5.19% | 27,423 | 697.00K |
| 353 | ELDN | Eledon Pharmaceuticals, Inc. | 116.48M | -7.19% | 1,458,796 | - |
| 354 | OVID | Ovid Therapeutics Inc. | 116.08M | 8.67% | 3,213,489 | 6.61M |
| 355 | IKT | Inhibikase Therapeutics, Inc. | 115.77M | -1.91% | 286,401 | 1.00 |
| 356 | GLSI | Greenwich LifeSciences, Inc. | 115.69M | -0.60% | 74,059 | - |
| 357 | ORMP | Oramed Pharmaceuticals Inc. | 114.63M | - | 272,210 | 2.00M |
| 358 | SLGL | Sol-Gel Technologies Ltd. | 113.35M | 0.76% | 8,028 | 18.97M |
| 359 | GANX | Gain Therapeutics, Inc. | 113.35M | 7.53% | 1,937,989 | - |
| 360 | ONCY | Oncolytics Biotech Inc. | 110.39M | 0.97% | 477,012 | - |
| 361 | SEER | Seer, Inc. | 109.34M | 1.55% | 57,737 | 16.38M |
| 362 | ENTX | Entera Bio Ltd. | 109.14M | -4.42% | 67,937 | 124.00K |
| 363 | WHWK | Whitehawk Therapeutics, Inc. | 108.40M | 6.98% | 182,049 | 14.38M |
| 364 | ATRA | Atara Biotherapeutics, Inc. | 107.14M | 1.99% | 63,003 | 151.93M |
| 365 | HURA | TuHURA Biosciences, Inc. | 107.13M | 7.73% | 205,763 | - |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 104.04M | - | 397,478 | 26.87M |
| 367 | ATOS | Atossa Therapeutics, Inc. | 100.73M | 1.14% | 628,461 | - |
| 368 | COEP | Coeptis Therapeutics Holdings, Inc. | 100.39M | 6.58% | 298,750 | 501.00K |
| 369 | TTRX | Turn Therapeutics Inc. | 100.11M | 3.03% | 84,749 | - |
| 370 | ADAG | Adagene Inc. | 99.92M | 6.53% | 173,746 | 103.20K |
| 371 | VANI | Vivani Medical, Inc. | 99.22M | 3.03% | 348,880 | - |
| 372 | ACET | Adicet Bio, Inc. | 97.18M | 0.18% | 4,710,390 | - |
| 373 | PLRX | Pliant Therapeutics, Inc. | 97.09M | 0.64% | 969,556 | - |
| 374 | ANEB | Anebulo Pharmaceuticals, Inc. | 96.14M | -6.02% | 149,712 | - |
| 375 | TVGN | Tevogen Bio Holdings Inc. | 95.57M | 9.64% | 786,457 | - |
| 376 | RPTX | Repare Therapeutics Inc. | 95.00M | 4.25% | 579,021 | 11.87M |
| 377 | KPTI | Karyopharm Therapeutics Inc. | 94.63M | 1.83% | 113,030 | 142.53M |
| 378 | MGNX | MacroGenics, Inc. | 93.62M | 2.07% | 397,973 | 127.63M |
| 379 | CRVO | CervoMed Inc. | 91.97M | 3.27% | 79,538 | 6.16M |
| 380 | ADVM | Adverum Biotechnologies, Inc. | 91.84M | 1.71% | 234,252 | 1.00M |
| 381 | THAR | Tharimmune, Inc. | 89.71M | 1.99% | 248,506 | - |
| 382 | CSBR | Champions Oncology, Inc. | 89.62M | - | 10,807 | 56.88M |
| 383 | HYFT | MindWalk Holdings Corp. | 88.62M | 7.26% | 1,312,100 | 18.21M |
| 384 | ARTV | Artiva Biotherapeutics, Inc. | 87.87M | 6.23% | 123,910 | 251.00K |
| 385 | PTHS | Pelthos Therapeutics Inc. | 87.26M | 5.13% | 24,099 | 7.41M |
| 386 | VXRT | Vaxart, Inc. | 86.24M | 2.27% | - | 148.20M |
| 387 | BYSI | BeyondSpring Inc. | 85.95M | 5.56% | 45,532 | 1.88M |
| 388 | FBIO | Fortress Biotech, Inc. | 85.66M | 2.60% | 294,530 | 62.30M |
| 389 | IMUX | Immunic, Inc. | 84.32M | -0.78% | 1,068,664 | - |
| 390 | PSTV | Plus Therapeutics, Inc. | 82.22M | 6.69% | 8,470,603 | 5.26M |
| 391 | TIL | Instil Bio, Inc. | 81.25M | 4.36% | 84,846 | - |
| 392 | IFRX | InflaRx N.V. | 80.62M | 0.85% | 524,417 | 73.73K |
| 393 | BMEA | Biomea Fusion, Inc. | 75.65M | 3.88% | 1,019,012 | - |
| 394 | STRO | Sutro Biopharma, Inc. | 75.46M | 3.06% | 525,391 | 105.65M |
| 395 | ATYR | aTyr Pharma, Inc. | 74.98M | -0.29% | 1,777,096 | 190.00K |
| 396 | ALXO | ALX Oncology Holdings Inc. | 74.82M | -4.83% | 143,561 | - |
| 397 | OTLK | Outlook Therapeutics, Inc. | 74.62M | 5.00% | 4,288,733 | 1.51M |
| 398 | ACRV | Acrivon Therapeutics, Inc. | 74.47M | 1.72% | 285,853 | - |
| 399 | IMA | ImageneBio, Inc. | 73.60M | -4.69% | 38,873 | 800.00K |
| 400 | OKYO | OKYO Pharma Limited | 73.34M | -2.21% | 186,547 | - |
| 401 | CBUS | Cibus, Inc. | 71.65M | -0.75% | 155,655 | 3.79M |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 71.30M | - | 216,291 | - |
| 403 | MNOV | MediciNova, Inc. | 71.12M | -4.61% | 119,002 | 257.92K |
| 404 | ESLA | Estrella Immunopharma, Inc. | 71.00M | 3.30% | 38,633 | - |
| 405 | LITS | Lite Strategy, Inc. | 70.63M | 4.35% | 601,329 | - |
| 406 | XBIT | XBiotech Inc. | 69.51M | -2.98% | 70,340 | - |
| 407 | NRXP | NRx Pharmaceuticals, Inc. | 65.75M | 7.34% | 356,303 | 242.00K |
| 408 | OSTX | OS Therapies Incorporated | 65.15M | 2.78% | 248,384 | - |
| 409 | MGX | Metagenomi, Inc. | 64.39M | 2.69% | 225,274 | 30.91M |
| 410 | VRCA | Verrica Pharmaceuticals Inc. | 63.68M | 31.05% | 1,155,147 | 30.83M |
| 411 | PYPD | PolyPid Ltd. | 63.21M | 3.26% | 64,457 | - |
| 412 | ATHE | Alterity Therapeutics Limited | 63.16M | 7.72% | 24,898 | 3.57M |
| 413 | TCRX | TScan Therapeutics, Inc. | 62.99M | 13.44% | 1,126,510 | 8.42M |
| 414 | ABVC | ABVC BioPharma, Inc. | 62.93M | 3.89% | 65,568 | 797.92K |
| 415 | EQ | Equillium, Inc. | 62.11M | 9.16% | 310,536 | 4.39M |
| 416 | ALGS | Aligos Therapeutics, Inc. | 60.67M | 2.07% | 49,309 | 2.65M |
| 417 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 60.12M | 3.18% | 1,865,964 | - |
| 418 | CVM | CEL-SCI Corporation | 60.03M | 11.92% | 67,812 | - |
| 419 | CALC | CalciMedica, Inc. | 59.08M | 3.80% | 38,462 | - |
| 420 | NTRB | Nutriband Inc. | 58.28M | 1.25% | 20,949 | 2.58M |
| 421 | CELU | Celularity Inc. | 56.09M | 0.51% | 15,988 | 40.58M |
| 422 | SNTI | Senti Biosciences, Inc. | 55.47M | 1.44% | 74,083 | - |
| 423 | IOBT | IO Biotech, Inc. | 52.81M | 0.94% | 390,601 | - |
| 424 | INKT | MiNK Therapeutics, Inc. | 52.39M | 2.29% | 6,953 | - |
| 425 | KRRO | Korro Bio, Inc. | 51.98M | -3.66% | 282,630 | 7.37M |
| 426 | ANL | Adlai Nortye Ltd. | 50.92M | -0.72% | 3,441 | 1.94M |
| 427 | BCAB | BioAtla, Inc. | 50.01M | 3.07% | 587,593 | 11.00M |
| 428 | CUE | Cue Biopharma, Inc. | 49.27M | 2.78% | 160,979 | 7.10M |
| 429 | JSPR | Jasper Therapeutics, Inc. | 48.83M | -0.29% | 197,181 | - |
| 430 | HOWL | Werewolf Therapeutics, Inc. | 47.42M | 7.33% | 255,897 | 1.14M |
| 431 | IPSC | Century Therapeutics, Inc. | 47.15M | 1.50% | 861,689 | 113.34M |
| 432 | EVAX | Evaxion A/S | 46.91M | 4.63% | 38,362 | 7.65M |
| 433 | NXTC | NextCure, Inc. | 46.18M | -2.29% | 48,201 | - |
| 434 | KZR | Kezar Life Sciences, Inc. | 45.62M | -0.80% | 14,832 | - |
| 435 | BTAI | BioXcel Therapeutics, Inc. | 45.49M | 8.90% | 652,832 | 752.00K |
| 436 | GNTA | Genenta Science S.p.A. | 45.46M | 1.04% | 93,227 | - |
| 437 | TELO | Telomir Pharmaceuticals, Inc. | 45.38M | 0.76% | 274,412 | - |
| 438 | GRCE | Grace Therapeutics, Inc. | 45.35M | 0.31% | 26,486 | - |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 45.23M | 3.57% | 94,529 | 90.00K |
| 440 | IBO | Impact BioMedical Inc. | 44.99M | -1.60% | 81,198 | 25.00K |
| 441 | PDSB | PDS Biotechnology Corporation | 44.50M | 9.08% | 580,931 | - |
| 442 | INMB | INmune Bio, Inc. | 43.87M | 8.55% | 533,869 | 50.00K |
| 443 | ICCC | ImmuCell Corporation | 43.42M | 2.56% | 24,444 | 27.77M |
| 444 | LTRN | Lantern Pharma Inc. | 42.50M | -0.78% | 75,859 | - |
| 445 | SKYE | Skye Bioscience, Inc. | 42.00M | 2.34% | 87,862 | - |
| 446 | SER | Serina Therapeutics, Inc. | 41.70M | - | 12,614 | 116.00K |
| 447 | RADX | Radiopharm Theranostics Limited | 41.67M | -0.43% | 3,534 | 8.20M |
| 448 | JUNS | Jupiter Neurosciences, Inc. | 41.66M | 2.54% | 25,456 | - |
| 449 | RNTX | Rein Therapeutics Inc. | 40.48M | 5.48% | 255,634 | - |
| 450 | XLO | Xilio Therapeutics, Inc. | 39.38M | -0.62% | 143,025 | 31.80M |
| 451 | MAIA | MAIA Biotechnology, Inc. | 39.25M | 9.29% | 382,949 | - |
| 452 | VERU | Veru Inc. | 39.16M | 2.09% | 83,661 | 16.89M |
| 453 | OKUR | OnKure Therapeutics, Inc. | 38.75M | 1.59% | 66,496 | - |
| 454 | APLT | Applied Therapeutics, Inc. | 38.12M | 6.06% | 6,991,458 | 1.00M |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 37.71M | 3.61% | 151,803 | - |
| 456 | GBIO | Generation Bio Co. | 35.78M | 1.14% | 12,366 | 15.27M |
| 457 | FGEN | FibroGen, Inc. | 35.68M | 3.04% | 36,543 | 8.30M |
| 458 | PLUR | Pluri Inc. | 35.26M | 1.87% | 38,123 | 1.33M |
| 459 | MURA | Mural Oncology plc | 35.00M | -3.81% | 2,218,498 | - |
| 460 | DYAI | Dyadic International, Inc. | 33.84M | -1.93% | 166,260 | 3.34M |
| 461 | APLM | Apollomics, Inc. | 32.71M | -5.58% | 10,760 | 198.00K |
| 462 | KLTO | Klotho Neurosciences, Inc. | 32.64M | -8.83% | 582,172 | - |
| 463 | RNXT | RenovoRx, Inc. | 32.48M | 2.40% | 247,896 | 928.00K |
| 464 | BRNS | Barinthus Biotherapeutics plc | 31.61M | 8.87% | 32,384 | 14.97M |
| 465 | QNTM | Quantum BioPharma Ltd. | 30.57M | 41.92% | 1,256,225 | - |
| 466 | HYPD | Hyperion DeFi, Inc. | 30.37M | 4.69% | 342,330 | 345.32K |
| 467 | LNAI | Lunai Bioworks Inc. | 30.23M | 19.44% | 3,164,625 | - |
| 468 | IGC | IGC Pharma, Inc. | 29.66M | 0.50% | 323,278 | 1.11M |
| 469 | NRSN | NeuroSense Therapeutics Ltd. | 29.30M | 12.50% | 681,918 | - |
| 470 | ANTX | AN2 Therapeutics, Inc. | 29.05M | -3.64% | 46,027 | - |
| 471 | PASG | Passage Bio, Inc. | 28.58M | 0.08% | 29,182 | - |
| 472 | NRXS | NeurAxis, Inc. | 28.44M | 0.75% | 82,290 | 3.36M |
| 473 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 28.37M | -0.12% | 1,376,422 | 1.00M |
| 474 | CLGN | CollPlant Biotechnologies Ltd. | 28.36M | -0.45% | 50,588 | 2.48M |
| 475 | RLYB | Rallybio Corporation | 27.16M | -0.96% | 160,542 | 674.00K |
| 476 | IBIO | iBio, Inc. | 26.98M | 2.56% | 944,206 | 500.00K |
| 477 | NERV | Minerva Neurosciences, Inc. | 26.44M | 0.27% | 26,447 | - |
| 478 | LIMN | Liminatus Pharma, Inc. | 26.42M | 10.28% | 305,251 | - |
| 479 | DARE | Daré Bioscience, Inc. | 25.86M | 2.26% | 64,033 | -57.13K |
| 480 | CTXR | Citius Pharmaceuticals, Inc. | 25.86M | 14.75% | 1,911,150 | - |
| 481 | QTTB | Q32 Bio Inc. | 25.35M | 1.48% | 25,890 | - |
| 482 | LEXX | Lexaria Bioscience Corp. | 24.91M | 3.70% | 118,970 | 615.92K |
| 483 | BOLD | Boundless Bio, Inc. | 24.85M | - | 1,348,155 | - |
| 484 | CING | Cingulate Inc. | 24.80M | -0.54% | 87,238 | - |
| 485 | ITRM | Iterum Therapeutics plc | 24.76M | 7.03% | 663,258 | 390.00K |
| 486 | XCUR | Exicure, Inc. | 24.60M | 1.05% | 13,810 | 500.00K |
| 487 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.01M | 2.93% | 111,702 | - |
| 488 | INTS | Intensity Therapeutics, Inc. | 23.80M | 0.20% | 964,432 | - |
| 489 | NEUP | Neuphoria Therapeutics Inc. | 23.45M | -4.39% | 102,562 | 15.65M |
| 490 | GLTO | Galecto, Inc. | 23.08M | 4.89% | 162,564 | - |
| 491 | NNVC | NanoViricides, Inc. | 22.68M | 7.69% | 210,966 | - |
| 492 | PTN | Palatin Technologies, Inc. | 22.39M | -8.71% | 68,052 | 8.85M |
| 493 | GDTC | CytoMed Therapeutics Limited | 21.93M | 0.04% | 15,452 | 573.19K |
| 494 | ENLV | Enlivex Therapeutics Ltd. | 21.86M | -8.16% | 2,989,117 | - |
| 495 | APVO | Aptevo Therapeutics Inc. | 21.57M | 6.67% | 468,175 | - |
| 496 | CASI | CASI Pharmaceuticals, Inc. | 20.75M | -10.62% | 36,674 | 26.85M |
| 497 | TRAW | Traws Pharma, Inc. | 20.46M | -2.66% | 69,838 | 2.85M |
| 498 | MRKR | Marker Therapeutics, Inc. | 20.34M | 10.91% | 703,773 | 4.69M |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 19.47M | -5.44% | 22,150 | - |
| 500 | SYBX | Synlogic, Inc. | 19.30M | -1.20% | 4,523 | 8.00K |
| 501 | BCTX | BriaCell Therapeutics Corp. | 18.62M | 6.63% | 52,346 | - |
| 502 | HOTH | Hoth Therapeutics, Inc. | 18.62M | 2.56% | 89,743 | - |
| 503 | ABP | Abpro Holdings, Inc. | 18.50M | -1.16% | 28,186 | 183.00K |
| 504 | KZIA | Kazia Therapeutics Limited | 18.27M | -22.13% | 406,104 | 1.20M |
| 505 | LPCN | Lipocine Inc. | 18.21M | 0.31% | 34,320 | 4.32M |
| 506 | MTVA | MetaVia Inc. | 18.17M | 5.16% | 123,520 | - |
| 507 | ALLR | Allarity Therapeutics, Inc. | 18.16M | 5.93% | 132,180 | - |
| 508 | LSTA | Lisata Therapeutics, Inc. | 18.08M | 0.97% | 36,095 | 1.07M |
| 509 | ATHA | Athira Pharma, Inc. | 17.83M | 0.67% | 15,545 | - |
| 510 | NCEL | NewcelX Ltd. | 17.46M | 9.43% | 65,600 | - |
| 511 | OSRH | OSR Holdings, Inc. | 17.43M | -16.84% | 3,330,389 | -90.52K |
| 512 | QNRX | Quoin Pharmaceuticals, Ltd. | 17.38M | -7.09% | 41,475 | - |
| 513 | NCNA | NuCana plc | 16.52M | 3.12% | 44,644 | - |
| 514 | PULM | Pulmatrix, Inc. | 16.40M | 3.94% | 14,961 | 3.00K |
| 515 | CRIS | Curis, Inc. | 16.16M | 10.62% | 171,859 | 11.65M |
| 516 | AKTX | Akari Therapeutics, Plc | 15.94M | - | 114,839 | - |
| 517 | CANF | Can-Fite BioPharma Ltd. | 15.62M | - | 1,629,017 | 560.00K |
| 518 | PMN | ProMIS Neurosciences, Inc. | 15.58M | -8.68% | 1,384,182 | - |
| 519 | CMMB | Chemomab Therapeutics Ltd. | 15.57M | 4.55% | 81,391 | - |
| 520 | FBLG | FibroBiologics, Inc. | 15.46M | 1.53% | 2,625,766 | - |
| 521 | KAPA | Kairos Pharma, Ltd. | 15.41M | 0.82% | 88,055 | - |
| 522 | BCDA | BioCardia, Inc. | 15.18M | - | 94,652 | 3.00K |
| 523 | BLRX | BioLineRx Ltd. | 15.17M | -2.96% | 19,778 | 12.74M |
| 524 | DWTX | Dogwood Therapeutics, Inc. | 14.95M | 1.40% | 12,699 | - |
| 525 | SNGX | Soligenix, Inc. | 14.83M | 4.26% | 170,052 | 2.34K |
| 526 | CLRB | Cellectar Biosciences, Inc. | 14.63M | 12.38% | 87,761 | - |
| 527 | MBRX | Moleculin Biotech, Inc. | 14.25M | -22.03% | 8,641,375 | - |
| 528 | TPST | Tempest Therapeutics, Inc. | 14.25M | 0.31% | 271,721 | - |
| 529 | PCSA | Processa Pharmaceuticals, Inc. | 14.24M | 3.80% | 964,110 | - |
| 530 | COCP | Cocrystal Pharma, Inc. | 14.06M | 8.31% | 80,918 | - |
| 531 | LGVN | Longeveron Inc. | 13.81M | 7.02% | 712,828 | 1.44M |
| 532 | PHIO | Phio Pharmaceuticals Corp. | 13.24M | 2.50% | 374,904 | - |
| 533 | AIXC | AIxCrypto Holdings, Inc. | 13.16M | 4.51% | 94,292 | - |
| 534 | VYNE | VYNE Therapeutics Inc. | 12.52M | -1.88% | 1,041,129 | 524.00K |
| 535 | EDSA | Edesa Biotech, Inc. | 12.03M | 1.79% | 17,590 | - |
| 536 | GOVX | GeoVax Labs, Inc. | 11.88M | 5.43% | 498,127 | 3.35M |
| 537 | IMNN | Imunon, Inc. | 11.85M | 1.58% | 15,452 | - |
| 538 | IMRN | Immuron Limited | 11.83M | 1.72% | 20,598 | 4.78M |
| 539 | ASBP | Aspire Biopharma Holdings, Inc. | 11.18M | 2.77% | 13,688,077 | 1.94K |
| 540 | ICU | SeaStar Medical Holding Corporation | 10.97M | -4.28% | 17,276,967 | 881.00K |
| 541 | BIVI | BioVie Inc. | 10.93M | 7.41% | 64,545 | - |
| 542 | APM | Aptorum Group Limited | 10.91M | 5.51% | 83,369 | - |
| 543 | ERNA | Ernexa Therapeutics Inc. | 10.83M | 2.22% | 25,843 | 1,000.00 |
| 544 | CLDI | Calidi Biotherapeutics, Inc. | 10.83M | 5.71% | 80,603 | - |
| 545 | PPCB | Propanc Biopharma, Inc. | 10.76M | -1.95% | 26,110 | - |
| 546 | SNSE | Sensei Biotherapeutics, Inc. | 10.66M | -1.74% | 2,711 | - |
| 547 | EVGN | Evogene Ltd. | 9.96M | 3.18% | 21,061 | 8.02M |
| 548 | CELZ | Creative Medical Technology Holdings, Inc. | 9.87M | -2.55% | 83,770 | 6.00K |
| 549 | BRTX | BioRestorative Therapies, Inc. | 9.76M | -0.90% | 29,717 | 383.40K |
| 550 | AEON | AEON Biopharma, Inc. | 9.73M | 0.14% | 92,780 | - |
| 551 | ENTO | Entero Therapeutics, Inc. | 9.65M | 2.87% | 44,586 | - |
| 552 | BOLT | Bolt Biotherapeutics, Inc. | 9.50M | -2.17% | 14,940 | 5.20M |
| 553 | INAB | IN8bio, Inc. | 9.32M | 6.35% | 51,271 | - |
| 554 | MBIO | Mustang Bio, Inc. | 9.05M | 5.08% | 125,812 | - |
| 555 | TOVX | Theriva Biologics, Inc. | 8.68M | 7.79% | 2,163,191 | - |
| 556 | GTBP | GT Biopharma, Inc. | 8.53M | 7.25% | 675,916 | - |
| 557 | ALZN | Alzamend Neuro, Inc. | 8.52M | 4.67% | 94,935 | - |
| 558 | RNAZ | TransCode Therapeutics, Inc. | 8.45M | 0.33% | 2,633 | - |
| 559 | KTTA | Pasithea Therapeutics Corp. | 7.89M | 117.39% | 159,521,876 | - |
| 560 | APRE | Aprea Therapeutics, Inc. | 7.89M | 3.31% | 10,128 | 488.24K |
| 561 | ACXP | Acurx Pharmaceuticals, Inc. | 7.82M | -3.10% | 51,362 | - |
| 562 | XTLB | XTL Biopharmaceuticals Ltd. | 7.55M | 1.79% | 25,790 | 451.00K |
| 563 | TCRT | Alaunos Therapeutics, Inc. | 7.50M | -2.61% | 31,283 | 6.00K |
| 564 | KALA | KALA BIO, Inc. | 7.47M | 42.63% | 31,686,995 | - |
| 565 | ADXN | Addex Therapeutics Ltd | 7.46M | 6.85% | 5,092 | 210.35K |
| 566 | ADIL | Adial Pharmaceuticals, Inc. | 7.44M | 0.98% | 528,355 | - |
| 567 | BGMS | Bio Green Med Solution, Inc. | 7.35M | 11.11% | 66,331 | 81.00K |
| 568 | PHGE | BiomX Inc. | 7.18M | -18.69% | 102,164 | - |
| 569 | KPRX | Kiora Pharmaceuticals, Inc. | 6.90M | 4.44% | 34,509 | 20.00K |
| 570 | PPBT | Purple Biotech Ltd | 6.63M | -0.85% | 139,950 | - |
| 571 | GRI | GRI Bio, Inc. | 6.47M | -3.88% | 103,994 | - |
| 572 | ENSC | Ensysce Biosciences, Inc. | 6.27M | 4.12% | 90,114 | 4.49M |
| 573 | LYRA | Lyra Therapeutics, Inc. | 6.21M | 21.53% | 1,010,585 | 600.00K |
| 574 | PLRZ | Polyrizon Ltd. | 6.18M | -10.45% | 400,315 | - |
| 575 | SILO | Silo Pharma, Inc. | 5.99M | 4.17% | 145,435 | 72.10K |
| 576 | XBIO | Xenetic Biosciences, Inc. | 5.93M | 2.78% | 12,895 | 2.86M |
| 577 | CYCN | Cyclerion Therapeutics, Inc. | 5.79M | 3.40% | 42,132 | 2.86M |
| 578 | VIVS | VivoSim Labs, Inc. | 5.74M | 0.46% | 39,211 | 140.00K |
| 579 | PMCB | PharmaCyte Biotech, Inc. | 5.60M | -7.46% | 1,628,719 | - |
| 580 | REVB | Revelation Biosciences, Inc. | 5.52M | 11.14% | 130,375 | - |
| 581 | SLRX | Salarius Pharmaceuticals, Inc. | 5.42M | 4.79% | 337,522 | - |
| 582 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.37M | 0.34% | 24,735 | 15.78K |
| 583 | HCWB | HCW Biologics Inc. | 5.27M | 1.56% | 22,480 | 422.03K |
| 584 | GLMD | Galmed Pharmaceuticals Ltd. | 5.06M | 12.40% | 266,281 | - |
| 585 | JAGX | Jaguar Health, Inc. | 4.78M | 3.23% | 71,314 | 11.79M |
| 586 | GNPX | Genprex, Inc. | 4.73M | -1.69% | 192,121 | - |
| 587 | MTNB | Matinas BioPharma Holdings, Inc. | 4.68M | 0.75% | 83,470 | - |
| 588 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.44M | 1.94% | 31,640 | 1.36M |
| 589 | XRTX | XORTX Therapeutics Inc. | 4.34M | 2.10% | 20,265 | - |
| 590 | PTIX | Protagenic Therapeutics, Inc. | 4.30M | - | 85,901 | - |
| 591 | CNSP | CNS Pharmaceuticals, Inc. | 4.18M | -0.30% | 11,134 | - |
| 592 | ELAB | PMGC Holdings Inc. | 3.93M | 0.76% | 5,437 | -241.53K |
| 593 | INDP | Indaptus Therapeutics, Inc. | 3.91M | 19.00% | 40,068 | - |
| 594 | OGEN | Oragenics, Inc. | 3.79M | -3.19% | 19,545 | - |
| 595 | AZTR | Azitra, Inc. | 3.64M | 15.13% | 1,290,365 | 7.50K |
| 596 | ONCO | Onconetix, Inc. | 3.64M | 3.56% | 32,016 | 1.22M |
| 597 | SPRC | SciSparc Ltd. | 3.60M | -9.02% | 51,151,505 | 1.31M |
| 598 | ENVB | Enveric Biosciences, Inc. | 3.45M | -2.69% | 21,193 | - |
| 599 | CDT | CDT Equity Inc. | 3.37M | 12.50% | 668,662 | - |
| 600 | ARTL | Artelo Biosciences, Inc. | 3.35M | -4.05% | 44,122 | - |
| 601 | DRMA | Dermata Therapeutics, Inc. | 3.11M | 2.36% | 50,375 | - |
| 602 | SCNI | Scinai Immunotherapeutics Ltd. | 2.98M | 1.34% | 23,293 | 1.15M |
| 603 | PBM | Psyence Biomedical Ltd. | 2.96M | -1.25% | 243,090 | - |
| 604 | CLSD | Clearside Biomedical, Inc. | 2.94M | -6.45% | 2,501,825 | 3.33M |
| 605 | BDRX | Biodexa Pharmaceuticals Plc | 2.69M | 11.35% | 36,693 | 104.90K |
| 606 | ADTX | Aditxt, Inc. | 1.76M | 19.39% | 2,426,056 | 5.95K |
| 607 | VRAX | Virax Biolabs Group Limited | 1.74M | -0.86% | 103,773 | 6.33K |
| 608 | SLXN | Silexion Therapeutics Corp | 1.62M | 20.42% | 160,015 | - |
| 609 | MLEC | Moolec Science SA | 1.61M | -3.96% | 75,661 | 7.83M |
| 610 | CMND | Clearmind Medicine Inc. | 847.85K | -3.06% | 18,050,483 | - |